Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Aug 09, 2016 $16.01 $16.01 $16.01 $16.01 264 400
Aug 08, 2016 $15.20 $15.20 $15.20 $15.20 50 500
Aug 05, 2016 $15.63 $15.63 $15.63 $15.63 57 900
Aug 04, 2016 $15.25 $15.25 $15.25 $15.25 85 900
Aug 03, 2016 $15.51 $15.51 $15.51 $15.51 47 000
Aug 02, 2016 $14.94 $14.94 $14.94 $14.94 54 600
Aug 01, 2016 $15.25 $15.25 $15.25 $15.25 56 900
Jul 29, 2016 $15.03 $15.03 $15.03 $15.03 110 700
Jul 28, 2016 $15.18 $15.18 $15.18 $15.18 53 800
Jul 27, 2016 $15.57 $15.57 $15.57 $15.57 77 900
Jul 26, 2016 $15.18 $15.18 $15.18 $15.18 112 500
Jul 25, 2016 $15.44 $15.44 $15.44 $15.44 59 200
Jul 22, 2016 $15.69 $15.69 $15.69 $15.69 45 500
Jul 21, 2016 $15.64 $15.64 $15.64 $15.64 73 200
Jul 20, 2016 $15.72 $15.72 $15.72 $15.72 83 900
Jul 19, 2016 $15.39 $15.39 $15.39 $15.39 41 700
Jul 18, 2016 $15.64 $15.64 $15.64 $15.64 71 700
Jul 15, 2016 $15.69 $15.69 $15.69 $15.69 72 300
Jul 14, 2016 $15.16 $15.16 $15.16 $15.16 114 700
Jul 13, 2016 $15.55 $15.55 $15.55 $15.55 71 100
Jul 12, 2016 $15.99 $15.99 $15.99 $15.99 102 800
Jul 11, 2016 $15.97 $15.97 $15.97 $15.97 105 600
Jul 08, 2016 $15.81 $15.81 $15.81 $15.81 67 700
Jul 07, 2016 $15.57 $15.57 $15.57 $15.57 54 900
Jul 06, 2016 $15.41 $15.41 $15.41 $15.41 71 600
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT